About Vijay Pande
Form D filings for Inceptive Nucleics in 2023 list Vijay Pande as director.
Vijay Pande first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Vijay Pande in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vijay Pande works with at each company, as listed on that company's latest Form D.
Inceptive Nucleics, Inc. · Form D, Sep 20, 2023
JU
Jakob Uszkoreit
Chief Executive Officer and director
KH
Kevin Heyries
Executive officer
DA
Diana Ajuria
Executive officer
DK
Do Soon Kim
Executive officer